Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
84
|
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2016 |
Cocaine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
199
|
39
|
0.300 |
None |
1.000 |
2 |
|
2006 |
2010 |
Hyperalgesia, Primary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2016 |
Hyperalgesia, Secondary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
88
|
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2016 |
Tactile Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
114
|
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2016 |
Hyperalgesia, Thermal
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
154
|
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2016 |
Cholestasis, Extrahepatic
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Gliosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
102
|
3
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Head and Neck Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
124
|
11
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Head Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
18
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Female infertility
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
37
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neck Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
132
|
1
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Nerve Degeneration
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
165
|
17
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cardiomyopathies, Primary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
108
|
1
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Pyemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Pathologic Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Myocardial Diseases, Secondary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Sezary Syndrome
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
196
|
7
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Sterility, Postpartum
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
28
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Substance Withdrawal Syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
80
|
5
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Drug Withdrawal Symptoms
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Sign or Symptom
|
58
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |